Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | HES1 |
| Upstream (Parents) |
|---|
| (<<) ENO1 → HES1 |
| (<<) TFAP2A → HES1 |
| (<<) MAF → HES1 |
| (<<) IRF1 → HES1 |
| (<<) JUND → HES1 |
| (<<) C5orf41 → HES1 |
| (<<) FOXP1 → HES1 |
| (<<) UBN1 → HES1 |
| (<<) TAF12 → HES1 |
| (<<) ZNF281 → HES1 |
| (<<) HMG20B → HES1 |
| (<<) NFYB → HES1 |
| (<<) EDF1 → HES1 |
| (<<) STAT2 → HES1 |
| Downstream (Children) |
|---|
| HES1 → HOXC10 (>>) |
| HES1 → WT1 (>>) |
| HES1 → MMP14 (>>) |
| HES1 → BHLHE40 (>>) |
| HES1 → TBX1 (>>) |
| HES1 → ZNF643 (>>) |
| HES1 → CEBPA (>>) |
| HES1 → EGR2 (>>) |
| HES1 → CREB1 (>>) |
| HES1 → ATF5 (>>) |
| HES1 → BCL6 (>>) |
| HES1 → ZNF277 (>>) |
| HES1 → HOXD10 (>>) |
| HES1 → TCF3 (>>) |
| HES1 → NR4A3 (>>) |
| HES1 → HMGB1 (>>) |
| HES1 → CEBPD (>>) |
| HES1 → ELF4 (>>) |
| HES1 → NFIL3 (>>) |
| HES1 → TAF5 (>>) |
| HES1 → DRAP1 (>>) |
| HES1 → JUN (>>) |
| HES1 → SUPT4H1 (>>) |
| HES1 → MSL3 (>>) |
| HES1 → CCRN4L (>>) |
| HES1 → ARNT (>>) |
| HES1 → CBL (>>) |
| HES1 → SCML2 (>>) |
| HES1 → FBXW7 (>>) |
